PDIA4 is a potential therapeutic target for the treatment of glioblastoma because it controls the growth of glioblastoma cells by activating the PI3K/AKT/m-TOR pathway and suppressing apoptosis [22]. This evidence concerns the gene AKT1 and glioblastoma.